Applied Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APLT research report →
Companywww.appliedtherapeutics.com
Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG.
- CEO
- Les D. Funtleyder
- IPO
- 2019
- Employees
- 35
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $14.86M
- P/E
- -0.83
- P/S
- 14.86
- P/B
- -26.72
- EV/EBITDA
- -0.05
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -2845.50%
- Op Margin
- -9840.30%
- Net Margin
- -1813.80%
- ROE
- -65.63%
- ROIC
- -5074.94%
Growth & Income
- Revenue
- $455.00K · -95.45%
- Net Income
- $-105,624,000 · 11.81%
- EPS
- $-0.76 · 46.48%
- Op Income
- $-104,299,000
- FCF YoY
- -52.80%
Performance & Tape
- 52W High
- $1.50
- 52W Low
- $0.09
- 50D MA
- $0.15
- 200D MA
- $0.46
- Beta
- 2.08
- Avg Volume
- 15.80M
Get TickerSpark's AI analysis on APLT
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 3, 26 | Kanter Stacy J. | sell | 22,500 |
| Feb 3, 26 | Kanter Stacy J. | sell | 200,000 |
| Feb 3, 26 | Kanter Stacy J. | other | 42,500 |
| Feb 3, 26 | Kanter Stacy J. | sell | 16,500 |
| Dec 19, 25 | Hooks Corwin Dale | other | 312,500 |
| Feb 3, 26 | Hooks Corwin Dale | sell | 862,500 |
| Feb 3, 26 | Hooks Corwin Dale | other | 5,753 |
| Dec 19, 25 | Chinoporos Constantine | other | 437,500 |
| Feb 3, 26 | Chinoporos Constantine | sell | 1,000,000 |
| Feb 3, 26 | Chinoporos Constantine | other | 57,111 |
Our APLT Coverage
We haven't published any research on APLT yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate APLT Report →